Pancreatic Cancer Research

ResearcherPhilipps University of MarburgNo recent work listed

Karl Quint

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5091549864. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper

Papers 2

  1. Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer. First author DOI 10.2174/138161213804547312↗
  2. Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition. Co-author DOI 10.3892/ijo.2012.1648↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mina Maftouh · 1 shared paper, 2013 · strength 0.03
  2. Amir Avan · 1 shared paper, 2013 · strength 0.03
  3. Niccola Funel · 1 shared paper, 2013 · strength 0.03
  4. Godefridus J. Peters · 1 shared paper, 2013 · strength 0.03
  5. Elisa Giovannetti · 1 shared paper, 2013 · strength 0.03
  6. Adam Enver Frampton · 1 shared paper, 2013 · strength 0.03
  7. Pietro Di Fazio · 1 shared paper, 2012 · strength 0.03
  8. Felix Rückert · 1 shared paper, 2012 · strength 0.03
  9. Daniel Neureiter · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.